High leptin levels are often observed in human obesity and are implicated in obesity-related hypertension. Leptin levels have been found to be higher in hypertensive obese African-American women compared to normotensive African-American women, but a direct association between leptin and blood pressure could not be obtained. Additionally, increased adiposity has been associated with higher aortic stiffness in obese African-American women, but leptin was not included in the study. The effects of leptin on cardiovascular function in African women have not yet been determined. We hypothesised that leptin is directly associated with blood pressure and decreased arterial compliance and that leptin levels are significantly higher in hypertensive overweight/obese African women compared to normotensive overweight/obese African women. A case-case control study was performed which included 98 African women. The subjects were divided into lean normotensive (lean NT), overweight/obese normotensive (OW/OB NT) and overweight/obese hypertensive (OW/OB HT). The Finometer apparatus was used to obtain a more elaborate cardiovascular profile. Serum leptin and insulin levels as well as the HOMA-IR index were determined. Various anthropometric measures were obtained. Leptin levels were elevated (Pp0.05) in the OW/OB NT and HT groups compared to the lean NT group, but were similar in the OW/OB NT and HT groups. After adjusting for obesity, insulin resistance, hyperinsulinaemia and age, a direct positive correlation was obtained between leptin and systolic blood pressure (SBP) (Pp0.05; r ¼ 0.68) in the OW/OB HT group. Additionally, leptin also correlated negatively with arterial compliance (Pp0.05; r ¼ À0.76) and positively with pulse pressure (Pp0.05; r ¼ 0.71) in the OW/OB HT group. In conclusion, even though leptin levels were the same in OW/OB HT and NT African women, leptin was directly and positively associated with SBP and pulse pressure and negatively with C W only in OW/OB HT African women, independent of obesity, insulin-resistance, hyperinsulinaemia and age.
Introduction
In African adult populations, little more than a generation ago, increases in weight and blood pressure with age were slight. 1 However, in recent years, the situation has changed considerably in Southern African populations. 2 Obesity is associated with a spectrum of metabolic and cardiovascular disorders 3 and emerges as the single most important risk factor for hypertension in most population surveys, 4 yet the precise contribution of excess weight in causing essential hypertension in different ethnic groups has not been determined. 5 One of the ways in which excess adiposity could possibly contribute to hypertension is through increased leptin production. Leptin, the ob gene product, is predominantly expressed by white adipocytes 6 and correlates well with body fat mass. 7 Not surprisingly, leptin levels are invariably elevated in the obese compared to lean subjects 7 and have been found to be higher in obese hypertensive African-American women compared to obese normotensive African-American women. 8 Evidence suggests that elevated leptin levels may play an important role in the pathogenesis of obesity-related hypertension 9 and accordingly has been associated with increased blood pressure. [10] [11] [12] [13] [14] [15] The mechanisms associating leptin with blood pressure in obesityrelated hypertension are multiple. One mechanism has been the involvement of leptin in decreasing vascular function. 16 Leptin has been found to be independently associated with intima-media thickness of the common carotid artery 17 and impaired arterial distensibility, resulting in decreased arterial compliance. 16 Another possible mechanism is the activation of the sympathetic nervous system by leptin. 18 One of the main consequences of this activation is to cause renal sympathetic nerve activity to increase, leading to sodium retention, volume expansion and increased blood pressure. 19 Additionally, angiotensin II production also increases as a consequence of this activation, increasing plasma levels and resulting in vasoconstriction and blood pressure elevation. 19 However, the association between leptin and blood pressure via sympathetic stimulation was not investigated in this study and the focus will remain on vascular function.
The above-mentioned studies were conducted in non-African population groups. Recently, Wildman et al 20 determined in obese African-American women that excess body weight is associated with higher aortic stiffness in subjects between 20 and 30 years of age, but did not include leptin in the study. Since leptin levels are elevated in hypertensive obese African-American women compared to normotensive obese controls, 8 one may postulate that leptin could be one of the main contributors to decreased arterial compliance and increased blood pressure in this African-American subject group. However, El-Gharbawy et al 8 failed to show a direct association between leptin and blood pressure in obese hypertensive African-American women. Since both leptin and hypertension are associated with obesity, insulin resistance and hyperinsulinaemia, 21 El-Gharbawy et al 8 adjusted for these variables in an attempt to obtain this direct association.
Currently, no data are available on the effects of elevated leptin levels on cardiovascular function in hypertensive African women with increased adiposity. Owing to the above-mentioned discrepancies in African-American women, we hypothesise that leptin is directly associated with blood pressure and decreased arterial compliance in overweight/obese hypertensive (OW/OB HT) African women, independent of obesity, insulin resistance, hyperinsulinaemia and age. Additionally, we hypothesise that leptin levels are higher in OW/OB HT African women compared to overweight/obese normotensive (OW/OB NT) African women.
Materials and methods

Participants
A case-case control study was performed, which included a sample of 102 apparently healthy African women from a government institution in the North West Province, South Africa. Exclusion criteria were pregnancy, lactation and treatment for mental or neurological diseases requiring the use of any medication. Out of the total sample of 102 subjects, three groups were selected: firstly, a group of 35 lean normotensive (lean NT) subjects (body mass index (BMI) ¼ 18.5-24.9 kg/m 2 ), secondly, a group of 46 normotensive subjects, which consisted out of a combination of overweight (n ¼ 19) and obese (n ¼ 27) subjects (BMI ¼ 25-29.9 and X30 kg/m 2 , respectively) and thirdly, a group of 17 hypertensive subjects, also consisting out of a combination of overweight (n ¼ 6) and obese (n ¼ 11) subjects. The subjects were regarded as hypertensive if their blood pressure was X140 and/or X90 mmHg. 22 A total of 98 subjects have been included in the analysis of this paper. The four subjects who were excluded were the only lean hypertensive subjects in the total subject group, rendering the group too small for statistical use.
All research subjects gave informed consent in writing. The Ethics Committee of the North-West University approved the study.
Experimental procedure
During the course of the study, the subjects reported at a metabolic ward facility (consisting of 10 single bedrooms, a living room and a kitchen) at 18:00 in the evening. They were all introduced to the experimental set-up including the Finometer apparatus. The purpose of the introduction to the experimental set-up was to minimise anticipation stress. The subjects received a light meal at around 19:00, which excluded caffeine and alcohol, and went to sleep before 23:00. The purpose of the dietary restrictions was to enable a good night's sleep and a stable, resting blood pressure the next morning. Finometer recordings were obtained between 06:00 and 08:00 the next morning, after the overnight rest and before breakfast. Subjects were not permitted to walk around or have anything to eat or drink (except water) until all recordings were completed.
The subject was awake and lying in the Fowler's position in a quiet single bedroom while the Finometer device was connected to the subject. Blood pressure was recorded continuously for a period of at least 7 min. After a recording of at least 2 min, the Finometer performed a return-to-flow systolic calibration. This is an individual patientlevel adjustment, which calibrates the upper arm pressure of each specific subject with the finger pressure. Highest precision in blood pressure readings is obtained only after this calibration. From the 7 min continuous blood pressure recording of the Finometer, the average systolic and diastolic blood pressures were determined from the last 2 min of the recording.
The Finometer device computed all cardiovascular variables online and stored the data in result files on a hard disk. The systolic blood pressure (SBP), diastolic blood pressure (DBP), pulse pressure (PP), heart rate (HR), stroke volume (SV), cardiac output (CO), total peripheral resistance (TPR) and arterial compliance (C W ) were computed and stored. 23, 24 The vascular unloading technique of Penáz together with the Physiocal criteria of Wesseling provided reliable, noninvasive and continuous estimates of blood pressure, which is useable especially in comparative studies. 25, 26 Since the pressure waveform is available continuously, computations provide further information on the dynamics of the cardiovascular system, similar to intra-arterial measurements. 24, [27] [28] [29] [30] [31] Body mass and height measurements were also taken. These anthropometric measurements were performed according to standard methods as described by Norton and Olds. 32 Maximum height was measured to the nearest 0.1 cm, with the head in the Frankfort plane, by means of a stadiometer (Invicta, IP 1465, UK). Body mass was measured to the nearest 0.1 kg by means of a calibrated electronic scale (Precision Health Scale, A&D Company, Japan). During these measurements, the subjects had to stand erect with the feet together and without volitionally contracting the gluteal muscles. Percentage body fat was calculated using the equation of Jackson and Pollock. 33 After the Finometer recordings were taken, fasting blood samples were drawn from the vena cephalica or medial cubital vein and serum were prepared according to standard methods. Serum leptin levels were measured using a 125 I IRMA kit (Diagnostic Systems Laboratories, Inc., Cat No. DSL-23100). Analysis of insulin levels was performed by enzyme immunoassay (BioSource EUROPE S.A. Belgium; interassay CV-7.5%, no crossreactivity with human proinsulin). Serum lipids were determined on a Vitros DT60 II Chemistry System with Vitros DT slides.
Insulin sensitivity was estimated by the homeostatic model assessment (HOMA-IR index), that is, the product of plasma glucose and insulin, divided by 22.5. As the group sample obtained was not random, and selected on the basis of BMI, the HOMA-IR index was divided into tertiles. Groups with a HOMA-IR index above the third tertile (3.17) were regarded as insulin resistant.
Statistical analysis
The computer software package Statistica v/6.0 was used for the analysis of the data. The analysis of covariance (ANCOVA) was used to show significant differences between groups while adjusting for age. The results were seen as statistically significant when the P-value was less or equal to 0.05, which means that each of the three comparisons were tested on a 0.05/3 ¼ 0.017 level of significance. That is the same as to calculate 98.3% confidence intervals for each of the groups and to determine whether these intervals overlap. 34 Partial correlation coefficients were used to show associations between various variables. Linear regression analysis using the forward stepwise method was also used to assess associations between either SBP, DBP, PP, TPR or C W as dependent variables, and leptin, insulin, lowdensity lipoprotein cholesterol (LDLC), triglycerides and age as independent variables.
Results
Means, standard errors and confidence intervals of cardiovascular and anthropometric variables as well as leptin levels, insulin levels and HOMA-IR indexes are presented in Table 1 . Results were adjusted for age due to differences obtained (Pp0.07) between the OW/OB HT group and lean NT and OW/OB NT groups. Leptin levels were significantly higher in the OW/OB NT and OW/OB HT groups compared to the lean NT group, but leptin values of the OW/OB NT and HT groups were the same. C W was significantly decreased and PP significantly increased in the OW/OB HT group compared to the OW/OB NT group.
When performing Pearson's correlations between variables, leptin correlated positively with adiposity as expected (data not shown). In the lean NT group, leptin correlated with fat % (Pp0.01; r ¼ 0.54). In the OW/OB NT group, leptin correlated with BMI (Pp0.01; r ¼ 0.54), waist circumference (Pp0.01; r ¼ 0.58) and fat % (Pp0.01; r ¼ 0.57), and in the OW/OB HT group, leptin correlated with fat % (Pp0.01; r ¼ 0.53).
In an attempt to obtain direct associations between leptin and blood pressure, the data were additionally adjusted for obesity, insulin resistance and hyperinsulinaemia. Obesity was adjusted for by means of BMI (indicating overall obesity 35 ), waist circumference (indicating central or abdominal obesity 35 ) and fat % (indicating subcutaneous fat content 36 ). Insulin resistance was adjusted for by means of the HOMA-IR index and hyperinsulinaemia by measured serum insulin levels. Results of these partial correlations are shown in Table 2 .
After these adjustments, no correlations were obtained between leptin and the cardiovascular variables in the lean NT and OW/OB NT groups. However, in the OW/OB HT group, leptin showed a direct positive correlation with SBP (Pp0.05; r ¼ 0.68) and PP (Pp0.05; r ¼ 0.71) and a negative correlation with C W (Pp0.05; r ¼ À0.76).
To support this result, a stepwise regression analysis was performed (Table 3) . Using a stepwise linear regression analysis in the OW/OB HT group, with either SBP, DBP, PP, TPR or C W as dependent variables and leptin, insulin LDLC, triglycerides and age as independent variables, SBP, PP, TPR and C W could all be best explained by age, while DBP could be best explained by leptin ( Table 3) .
The strong influence of age on the cardiovascular profile, as observed in Table 3 , supports the adjustment for age when the partial correlations were determined. Owing to this strong influence of age, age was accordingly omitted from the multiple regression model (Table 4) .
By doing so (Table 4) , leptin was the main contributor to SBP and DBP, while insulin was the main contributor to PP. However, leptin accounted for 17.7% of the variance in PP (R 2 ¼ 0.504). The main contributors to TPR and C W were LDLC. Again, leptin was involved and accounted for 13.9 and 12.8% of the variance in TPR (R 2 ¼ 0.536) and C W (R 2 ¼ 0.464), respectively.
Discussion
Increased leptin levels in the obese have been under close scrutiny over the past decade 37 and have been shown to be an independent predictor of cardiovascular morbidity and mortality. [38] [39] [40] However, studies on leptin are limited in African populations 41, 42 and the effects of leptin on cardiovascular function in Africans are absent (Table 5) . Lean NT, lean normotensive; OW/OB NT, overweight/obese normotensive; OW/OB HT, overweight/obese hypertensive; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; SV, stroke volume; CO, cardiac output; TPR, total peripheral resistance; C W , Windkessel arterial compliance; PP, pulse pressure; Leptin, fasting leptin; Insulin, fasting insulin; Glucose, fasting glucose; HOMA-IR, homeostatic model assessment insulin resistance index; TC, total cholesterol; HDLC, high-density lipoprotein cholesterol; LDLC, low-density lipoprotein cholesterol; Trig, triglycerides; BMI, body mass index; Waist circum., waist circumference; fat %, fat percentage. Variables are adjusted for age at a 98.3% confidence interval. Means with the same superscript letter: statistically significant (Pp0.05). 
Lean NT, lean normotensive; OW/OB NT, overweight/obese normotensive; OW/OB HT, overweight/obese hypertensive; Leptin, fasting leptin; SBP, systolic blood pressure; DBP, diastolic blood pressure; PP, pulse pressure; TPR, total peripheral resistance; C W , Windkessel arterial compliance.
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Leptin is associated with increased adiposity 7 and accordingly, from the results, leptin levels were higher in the OW/OB NT and HT groups compared to the lean NT group. As expected, positive correlations were obtained between leptin and measures of increased adiposity in all three groups. However, leptin levels were similar between the OW/OB NT and HT groups, which are in contradiction with some studies. Leptin levels have been reported to be higher in patients with hypertension compared to normotensive controls 11, 43 and have been positively associated with blood pressure in various nonAfrican population groups. [10] [11] [12] [13] [14] [15] 43 El-Gharbawy et al 8 failed to obtain a direct positive association between leptin and blood pressure in obese hypertensive African-American women with leptin levels that were significantly higher in relation to a obese normotensive African-American female group. Since leptin is independently associated with intima-media thickness, 17 decreased arterial distensibility 16 (decreasing arterial compliance) and blood pressure [10] [11] [12] [13] [14] [15] 43 in non-African population groups, the findings by El-Gharbawy et al 8 seems surprising since the group under study was hyperleptinaemic and hypertensive. Additionally, Wildman et al 20 determined in obese African-American women that excess body weight is associated with higher aortic stiffness, but leptin was not included in the study. Thus, one could postulate that leptin could have contributed to the increased aortic stiffness, and hence, decreased C W .
El-Gharbawy et al 8 attempted to obtain the abovementioned direct association between leptin and blood pressure by adjusting for obesity, insulin resistance and hyperinsulinaemia, since these variables are associated with both leptin and hypertension. 21 In the present study, a similar route was taken and after these adjustments, no correlations were obtained between leptin and the cardiovascular profile in the lean NT and OW/OB NT groups. However, in the OW/OB HT group, a strong direct positive association was indeed obtained with SBP as well as a strong negative correlation with C W . This was supported by the positive correlation between leptin and PP, since decreased C W increases PP and SBP. 44 By performing multiple regression analyses to confirm the above-mentioned results, leptin showed strong associations with SBP and DBP after omitting age from the multiple regression model. Insulin along with leptin both contributed to the increased PP. LDLC, which did not differ significantly between the three groups, was the biggest contributor to the increased TPR and decreased C W in the OW/OB HT group. However, in both cases, leptin was also a prominent contributor.
The possible influence of leptin on blood pressure via the activation of the sympathetic nervous system cannot be ignored. In this instance, it was not feasible to determine this influence, since sympathetic activity was not measured. However, this influence does not seem probable since the mean Leptin and blood pressure in African women R Schutte et al
HRs of the three groups were similar, despite the significantly higher leptin levels in the OW/OB groups (Table 1 ) and the lack of correlations between leptin and HR in the different groups (Table 2) . It seems that leptin does not necessarily have to be elevated in OW/OB HT compared to OW/OB NT to exhibit its pathological effects. Since leptin receptors are expressed on the endothelium 45 and vascular smooth muscle cells, 46 leptin could possibly affect the function of these cell types and play a pro-atherogenic role in African women, decreasing arterial compliance and increasing PP and SBP.
In conclusion, even though leptin levels were the same in OW/OB HT and NT African women, leptin was directly and positively associated with SBP and PP and negatively with C W only in OW/OB HT African women, independent of obesity, insulinresistance, hyperinsulinaemia and age.
